Shock therapy gets a Brain-Targeted upgrade to save memories
NCT ID NCT04099342
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 33 times
Summary
This study tests a new version of electroconvulsive therapy (ECT) for people with treatment-resistant depression. The goal is to reduce memory loss, a common side effect, by placing electrodes on one side of the head to better target the brain's prefrontal cortex. About 20 adults will receive this modified ECT, and researchers will measure its effects on depression symptoms and memory. The approach aims to make ECT safer and more tolerable while keeping its benefits.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Conditions
Explore the condition pages connected to this study.